NCT03629847 2018-08-14Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin AnalogueKing Faisal Specialist Hospital & Research CenterPhase 1/2 Unknown30 enrolled